Company Summary

Sublimity Therapeutics Limited was set up on Saturday the 8th of April 2000. Their current partial address is Dublin 11, and the company status is Normal. The company has 7 directors who have also been the directors of 22 other Irish companies between them; 8 of which are now closed. Sublimity Therapeutics Limited has 1 shareholder.

Company Name:Sublimity Therapeutics Limited
Company Status:NORMAL
Company Address:Dcu Alpha,
Innovation Campus , Old Finglas Road,
Dublin 11
Telephone:+353 1 5715333
Website:www.sigmoidpharma.com
Key Executive:Mr Ryan
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Mr Ryan is a Company Director of Sublimity Therapeutics Limited since 2014 and a listed Director of 8 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Sublimity Therapeutics Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
RECTIFICATION OF THE REGISTER14/04/202021/08/2020Join Up
B10 CHANGE IN DIRECTORS/SECRETARY16/07/202021/08/2020Join Up
B10 CHANGE IN DIRECTORS/SECRETARY12/11/201903/12/2019Join Up
B1 ANNUAL RETURN30/09/201929/10/2019Join Up
ACCOUNT DETAILS31/12/201829/10/2019Join Up
THIS COMPANY HAS 172 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Sublimity Therapeutics Limited.

Company Status:Normal
Latest Credit Movement:
Date of Last Movement:29/11/2019
Latest Accounts Filed:29/10/2019
Report Based on Accounts:31/12/2018
Next Set of Accounts Due:30/09/2020
Overdue:No
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Sublimity Therapeutics Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirments on Sublimity Therapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Sublimity Therapeutics Limited and Anti-Money Laundering checks (AML checks) on Sublimity Therapeutics Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:1

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Sublimity Therapeutics Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

Get Ahead Of Your KYC/AML Checks Before Year End

20/10/2020

CRIFVision-net has helped many of our customers over the last few months get a step ahead of their due diligence

Read More »

Searching 200 Million Companies Worldwide Has Never Been Easier

20/10/2020

As the world continues to deal with the fallout from the COVID crisis, it has never been more important to be aware of the current status of your global trading partners.

Read More »

Over 5500 Financial Documents Uploaded To CRIFVision-net Last Week

14/10/2020

There's a good chance your customers and competitors have just filed their latest financial accounts

Read More »

Personal Insolvency Applications Reach A Record High In July

18/09/2020

The number of applications to the ISI have been higher in almost all months this year

Read More »